Harnessing a cRGD-Targeted Schottky Junction MXene Nanocomposite for Potent Bladder Cancer Therapy: Dual-Modal PTT/PDT Effects with Immune Activation and Favorable Comparison to Doxorubicin.

Saved in:
Bibliographic Details
Title: Harnessing a cRGD-Targeted Schottky Junction MXene Nanocomposite for Potent Bladder Cancer Therapy: Dual-Modal PTT/PDT Effects with Immune Activation and Favorable Comparison to Doxorubicin.
Authors: Gu Z; Department of Urology, Nantong First People's Hospital, Affiliated with Southeast University, Nantong, Jiangsu, 226200, People's Republic of China., Zhu H; Department of Urology, Nantong First People's Hospital, Affiliated with Southeast University, Nantong, Jiangsu, 226200, People's Republic of China., Zhang Y; Department of Urology, Nantong First People's Hospital, Affiliated with Southeast University, Nantong, Jiangsu, 226200, People's Republic of China., Jiang J; Department of Urology, Nantong First People's Hospital, Affiliated with Southeast University, Nantong, Jiangsu, 226200, People's Republic of China., Gu D; Department of Urology, Nantong First People's Hospital, Affiliated with Southeast University, Nantong, Jiangsu, 226200, People's Republic of China., Chen J; Department of Urology, Nantong First People's Hospital, Affiliated with Southeast University, Nantong, Jiangsu, 226200, People's Republic of China.
Source: International journal of nanomedicine [Int J Nanomedicine] 2026 Jun 12; Vol. 21, pp. 597220. Date of Electronic Publication: 2026 Jun 12 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1178-2013
DOI:10.2147/IJN.S597220